Search

Search Constraints

You searched for: Author/Creator Hites, Maya

Search Results

2. Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group. (January 2022)

3. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19. (December 2021)

5. Blood tolerogenic monocytes and low proportions of dendritic cell subpopulations are hallmarks of human tuberculosis. Issue 5 (28th February 2018)

6. Clinical Course and Risk Factors for Infection in Severe Forms of Alcohol‐Associated Liver Disease. Issue 5 (10th August 2021)

7. Early β‐lactam concentrations and infectious complications after lung transplantation. Issue 7 (25th December 2020)

8. Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial. Issue 12 (December 2021)

9. Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. (2nd March 2022)

10. Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial. Issue 10323 (29th January 2022)